Weight Loss & Metabolic
Incretin and metabolic research peptides - GLP-1, GIP, and lipolytic compounds.
Retatrutide 10mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 10mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 30mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 30mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Semaglutide 30mg | 10-Vial Kit | 300mg Total | GLP-1 Receptor Agonist
Semaglutide 30mg | 10-Vial Kit | 300mg Total | GLP-1 Receptor Agonist
Semaglutide 30mg β high-dose GLP-1R agonist research vial.
Adipotide 2mg | 10-Vial Kit | 20mg Total | Proapoptotic Adipose Peptide
Adipotide 2mg | 10-Vial Kit | 20mg Total | Proapoptotic Adipose Peptide
Adipotide 2mg | 10-Vial Kit β Proapoptotic peptidomimetic β selectively induces apoptosis in prohibitin-expressing white adipose vasculature, causingβ¦
AOD-9604 2mg | 10-Vial Kit | HGH Fragment
AOD-9604 2mg | 10-Vial Kit | HGH Fragment
AOD-9604 2mg | 10-Vial Kit β Modified GH C-terminal fragment (residues 177-191, Tyr substitution) β stimulates Ξ²3-adrenergic lipolysis and inhibitsβ¦
Semaglutide 15mg | 10-Vial Kit | GLP-1 Receptor Agonist
Semaglutide 15mg | 10-Vial Kit | GLP-1 Receptor Agonist
QSC Semaglutide (GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Retatrutide 50mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 50mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Semaglutide 10mg | 10-Vial Kit | GLP-1 Receptor Agonist
Semaglutide 10mg | 10-Vial Kit | GLP-1 Receptor Agonist
QSC Semaglutide (GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 15mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 15mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Retatrutide 10mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 10mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Retatrutide 30mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 30mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 10mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 10mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 30mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 30mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 5mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 5mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
AOD-9604 10mg | 10-Vial Kit | HGH Fragment
AOD-9604 10mg | 10-Vial Kit | HGH Fragment
AOD-9604 10mg | 10-Vial Kit β Modified GH C-terminal fragment (residues 177-191, Tyr substitution) β stimulates Ξ²3-adrenergic lipolysis and inhibitsβ¦
Retatrutide 30mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 30mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
ADAMAX 10mg | 10-Vial Kit | Metabolic Modulation
ADAMAX 10mg | 10-Vial Kit | Metabolic Modulation
ADAMAX 10mg | 10-Vial Kit β QSC cognitive-metabolic blend β combined NNMT inhibitor, NAD+ precursor, BDNF upregulator, and mitochondrial biogenesis agentsβ¦
AOD-9604 5mg | 10-Vial Kit | HGH Fragment
AOD-9604 5mg | 10-Vial Kit | HGH Fragment
AOD-9604 5mg | 10-Vial Kit β Modified GH C-terminal fragment (residues 177-191, Tyr substitution) β stimulates Ξ²3-adrenergic lipolysis and inhibitsβ¦
Cagrilintide 10mg | 10-Vial Kit | Appetite Regulation
Cagrilintide 10mg | 10-Vial Kit | Appetite Regulation
QSC Cagrilintide (Long-acting amylin receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
IGF-1 LR3 1mg | 10-Vial Kit | Muscle Growth Peptide
IGF-1 LR3 1mg | 10-Vial Kit | Muscle Growth Peptide
IGF-1 LR3 1mg | 10-Vial Kit β Long-arginine-3 IGF-1 analogue β 1000-fold reduced IGFBP binding affinity extends free half-life to 20-30 hours enablingβ¦
MOTS-c 40mg | 10-Vial Kit | Metabolic Regulator
MOTS-c 40mg | 10-Vial Kit | Metabolic Regulator
QSC MOTS-c (Mitochondria-derived peptide) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 60mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 60mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 40mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 40mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 20mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 20mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 10mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 10mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Orlistat 100G Raw Powder | Pancreatic Lipase Inhibitor
Orlistat 100G Raw Powder | Pancreatic Lipase Inhibitor
QSC Orlistat (Pancreatic Lipase Inhibitor / Anti-Obesity Agent) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Semaglutide 7mg Tablets | 25-Count
Semaglutide 7mg Tablets | 25-Count
QSC Semaglutide (GLP-1 Receptor Agonist (Fatty Acid-Modified)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Semaglutide 3mg Tablets | 25-Count
Semaglutide 3mg Tablets | 25-Count
QSC Semaglutide (GLP-1 Receptor Agonist (Fatty Acid-Modified)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Semaglutide 500mcg Tablets | 25-Count
Semaglutide 500mcg Tablets | 25-Count
QSC Semaglutide (GLP-1 Receptor Agonist (Fatty Acid-Modified)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 500mcg Tablets | 25-Count
Tirzepatide 500mcg Tablets | 25-Count
QSC Tirzepatide (Dual GIP/GLP-1 Receptor Agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Orlistat 1KG Raw Powder | Pancreatic Lipase Inhibitor
Orlistat 1KG Raw Powder | Pancreatic Lipase Inhibitor
QSC Orlistat (Pancreatic Lipase Inhibitor / Anti-Obesity Agent) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tesofensine 100G Raw Powder | Triple Monoamine Reuptake Inhibitor
Tesofensine 100G Raw Powder | Triple Monoamine Reuptake Inhibitor
QSC Tesofensine (Triple Monoamine Reuptake Inhibitor (SNRI + DRI)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Liraglutide 30mg | 20-Vial Kit | GLP-1 Receptor Agonist
Liraglutide 30mg | 20-Vial Kit | GLP-1 Receptor Agonist
Liraglutide 30mg | 20-Vial Kit | GLP-1 receptor agonist β stimulates insulin secretion and suppresses glucagon in a glucose-dependent manner.
Liraglutide 30mg | 10-Vial Kit | GLP-1 Receptor Agonist
Liraglutide 30mg | 10-Vial Kit | GLP-1 Receptor Agonist
Liraglutide 30mg | 10-Vial Kit | GLP-1 receptor agonist β stimulates insulin secretion and suppresses glucagon in a glucose-dependent manner.
SLU-PP-332 20mg Tablets | 200-Count | ERR Agonist
SLU-PP-332 20mg Tablets | 200-Count | ERR Agonist
QSC SLU-PP-332 (ERRΞ±/ERRΞ³ nuclear receptor agonist β exercise mimetic) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Liraglutide 5mg | 20-Vial Kit | GLP-1 Receptor Agonist
Liraglutide 5mg | 20-Vial Kit | GLP-1 Receptor Agonist
Liraglutide 5mg | 20-Vial Kit | GLP-1 receptor agonist β stimulates insulin secretion and suppresses glucagon in a glucose-dependent manner.
Liraglutide 10mg | 20-Vial Kit | GLP-1 Receptor Agonist
Liraglutide 10mg | 20-Vial Kit | GLP-1 Receptor Agonist
Liraglutide 10mg | 20-Vial Kit | GLP-1 receptor agonist β stimulates insulin secretion and suppresses glucagon in a glucose-dependent manner.
ADAMAX 5mg | 20-Vial Kit | Metabolic Modulation
ADAMAX 5mg | 20-Vial Kit | Metabolic Modulation
ADAMAX 5mg | 20-Vial Kit β QSC cognitive-metabolic blend β combined NNMT inhibitor, NAD+ precursor, BDNF upregulator, and mitochondrial biogenesis agentsβ¦
Tirzepatide 50mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 50mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Semaglutide 30mg | 20-Vial Kit | 600mg Total | GLP-1 Receptor Agonist
Semaglutide 30mg | 20-Vial Kit | 600mg Total | GLP-1 Receptor Agonist
Semaglutide 30mg β high-dose GLP-1R agonist research vial.
Retatrutide 40mg | 20-Vial Kit | 800mg Total | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 40mg | 20-Vial Kit | 800mg Total | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 40mg β triple GLP-1R/GIPR/GCGR agonist, 24.2% Phase 2 weight loss.
Retatrutide + Cagrilintide Blend 10mg | 20-Vial Kit | Triple/Dual Agonist Stack
Retatrutide + Cagrilintide Blend 10mg | 20-Vial Kit | Triple/Dual Agonist Stack
Retatrutide + Cagrilintide Blend 10mg | 20-Vial Kit β Long-acting amylin receptor agonist β reduces food intake via area postrema satiety signalling, slowsβ¦
Mazdutide 5mg | 20-Vial Kit | 100mg Total | GLP-1/GCGR Dual Agonist
Mazdutide 5mg | 20-Vial Kit | 100mg Total | GLP-1/GCGR Dual Agonist
Mazdutide 5mg β dual GLP-1R/GCGR agonist, Phase 3 weight loss compound.
Cagrilintide 20mg | 20-Vial Kit | Appetite Regulation
Cagrilintide 20mg | 20-Vial Kit | Appetite Regulation
QSC Cagrilintide (Long-acting amylin receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
AOD-9604 2mg | 20-Vial Kit | HGH Fragment
AOD-9604 2mg | 20-Vial Kit | HGH Fragment
AOD-9604 2mg | 20-Vial Kit β Modified GH C-terminal fragment (residues 177-191, Tyr substitution) β stimulates Ξ²3-adrenergic lipolysis and inhibitsβ¦
Adipotide 2mg | 20-Vial Kit | 40mg Total | Proapoptotic Adipose Peptide
Adipotide 2mg | 20-Vial Kit | 40mg Total | Proapoptotic Adipose Peptide
Adipotide 2mg | 20-Vial Kit β Proapoptotic peptidomimetic β selectively induces apoptosis in prohibitin-expressing white adipose vasculature, causingβ¦
5-Amino-1MQ 10mg | 20-Vial Kit | NNMT Inhibitor
5-Amino-1MQ 10mg | 20-Vial Kit | NNMT Inhibitor
QSC 5-Amino-1MQ (NNMT inhibitor) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
ADAMAX 5mg | 10-Vial Kit | Metabolic Modulation
ADAMAX 5mg | 10-Vial Kit | Metabolic Modulation
ADAMAX 5mg | 10-Vial Kit β QSC cognitive-metabolic blend β combined NNMT inhibitor, NAD+ precursor, BDNF upregulator, and mitochondrial biogenesis agentsβ¦
Cagrilintide 20mg | 10-Vial Kit | Appetite Regulation
Cagrilintide 20mg | 10-Vial Kit | Appetite Regulation
QSC Cagrilintide (Long-acting amylin receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
5-Amino-1MQ 5mg | 20-Vial Kit | 100mg Total | NNMT Inhibitor
5-Amino-1MQ 5mg | 20-Vial Kit | 100mg Total | NNMT Inhibitor
5-Amino-1MQ 5mg β NNMT inhibitor, NAD+ elevation, fat oxidation research.
Survodutide 10mg | 20-Vial Kit | Dual GLP-1/Glucagon Kit
Survodutide 10mg | 20-Vial Kit | Dual GLP-1/Glucagon Kit
QSC Survodutide (Dual GLP-1R/GCGR agonist (BI 456906)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Mazdutide 10mg | 20-Vial Kit | GLP-1/Glucagon Dual Agonist
Mazdutide 10mg | 20-Vial Kit | GLP-1/Glucagon Dual Agonist
QSC Mazdutide (IBI362, Dual GLP-1R/GCGR agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Cagrilintide + Semaglutide Blend 10mg | 20-Vial Kit | Weight Loss Stack
Cagrilintide + Semaglutide Blend 10mg | 20-Vial Kit | Weight Loss Stack
Cagrilintide + Semaglutide Blend 10mg | 20-Vial Kit β Long-acting amylin receptor agonist β reduces food intake via area postrema satiety signalling, slowsβ¦
Tirzepatide 40mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 40mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
ADAMAX 10mg | 20-Vial Kit | Metabolic Modulation
ADAMAX 10mg | 20-Vial Kit | Metabolic Modulation
ADAMAX 10mg | 20-Vial Kit β QSC cognitive-metabolic blend β combined NNMT inhibitor, NAD+ precursor, BDNF upregulator, and mitochondrial biogenesis agentsβ¦
HGH Fragment 176-191 10mg | 20-Vial Kit | Lipolytic Peptide
HGH Fragment 176-191 10mg | 20-Vial Kit | Lipolytic Peptide
HGH Fragment 176-191 10mg | 20-Vial Kit β GH C-terminal fragment (residues 176-191) β activates Ξ²3-adrenergic receptors to drive fat oxidation withoutβ¦
Lemon Bottle (Riboflavin + Bromelain + Lecithin) | Lipolytic Injectable | 10-Vial Kit
Lemon Bottle (Riboflavin + Bromelain + Lecithin) | Lipolytic Injectable | 10-Vial Kit
Lemon Bottle (Riboflavin + Bromelain + Lecithin Lipolytic Complex) Injectable β Riboflavin + Bromelain + Lecithin lipolytic injectable complex β studied forβ¦
Liraglutide 10mg | 10-Vial Kit | GLP-1 Receptor Agonist
Liraglutide 10mg | 10-Vial Kit | GLP-1 Receptor Agonist
Liraglutide 10mg | 10-Vial Kit | GLP-1 receptor agonist β stimulates insulin secretion and suppresses glucagon in a glucose-dependent manner.
Liraglutide 5mg | 10-Vial Kit | GLP-1 Receptor Agonist
Liraglutide 5mg | 10-Vial Kit | GLP-1 Receptor Agonist
Liraglutide 5mg | 10-Vial Kit | GLP-1 receptor agonist β stimulates insulin secretion and suppresses glucagon in a glucose-dependent manner.
Tesamorelin 5mg | 20-Vial Kit | GHRH Analog | Egrifta
Tesamorelin 5mg | 20-Vial Kit | GHRH Analog | Egrifta
QSC Tesamorelin (GHRH(1-44) analog β FDA-approved Egrifta) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Retatrutide 60mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 60mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Retatrutide 5mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 5mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Retatrutide 50mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 50mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
MOTS-c 40mg | 20-Vial Kit | Metabolic Regulator
MOTS-c 40mg | 20-Vial Kit | Metabolic Regulator
QSC MOTS-c (Mitochondria-derived peptide) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
MOTS-c 10mg | 20-Vial Kit | Metabolic Regulator
MOTS-c 10mg | 20-Vial Kit | Metabolic Regulator
QSC MOTS-c (Mitochondria-derived peptide) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
IGF-1 LR3 1mg | 20-Vial Kit | Muscle Growth Peptide
IGF-1 LR3 1mg | 20-Vial Kit | Muscle Growth Peptide
IGF-1 LR3 1mg | 20-Vial Kit β Long-arginine-3 IGF-1 analogue β 1000-fold reduced IGFBP binding affinity extends free half-life to 20-30 hours enablingβ¦
HGH Fragment 176-191 5mg | 20-Vial Kit | Lipolytic Peptide
HGH Fragment 176-191 5mg | 20-Vial Kit | Lipolytic Peptide
HGH Fragment 176-191 5mg | 20-Vial Kit β GH C-terminal fragment (residues 176-191) β activates Ξ²3-adrenergic receptors to drive fat oxidation withoutβ¦
Glutathione 1500mg | 20-Vial Kit
Glutathione 1500mg | 20-Vial Kit
Glutathione 1500mg | 20-Vial Kit β Tripeptide master antioxidant (Ξ³-glutamylcysteinylglycine) β primary intracellular reducing agent for ROS, cofactor forβ¦
Cagrilintide 5mg | 20-Vial Kit | Appetite Regulation
Cagrilintide 5mg | 20-Vial Kit | Appetite Regulation
QSC Cagrilintide (Long-acting amylin receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Cagrilintide 10mg | 20-Vial Kit | Appetite Regulation
Cagrilintide 10mg | 20-Vial Kit | Appetite Regulation
QSC Cagrilintide (Long-acting amylin receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Semaglutide 5mg | 20-Vial Kit | GLP-1 Receptor Agonist
Semaglutide 5mg | 20-Vial Kit | GLP-1 Receptor Agonist
QSC Semaglutide (GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Semaglutide 2mg | 20-Vial Kit | GLP-1 Receptor Agonist
Semaglutide 2mg | 20-Vial Kit | GLP-1 Receptor Agonist
QSC Semaglutide (GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Semaglutide 20mg | 20-Vial Kit | GLP-1 Receptor Agonist
Semaglutide 20mg | 20-Vial Kit | GLP-1 Receptor Agonist
QSC Semaglutide (GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Semaglutide 15mg | 20-Vial Kit | GLP-1 Receptor Agonist
Semaglutide 15mg | 20-Vial Kit | GLP-1 Receptor Agonist
QSC Semaglutide (GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Semaglutide 10mg | 20-Vial Kit | GLP-1 Receptor Agonist
Semaglutide 10mg | 20-Vial Kit | GLP-1 Receptor Agonist
QSC Semaglutide (GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 60mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 60mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 100mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 100mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Retatrutide 20mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 20mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Retatrutide 15mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 15mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
AOD-9604 5mg | 20-Vial Kit | HGH Fragment
AOD-9604 5mg | 20-Vial Kit | HGH Fragment
AOD-9604 5mg | 20-Vial Kit β Modified GH C-terminal fragment (residues 177-191, Tyr substitution) β stimulates Ξ²3-adrenergic lipolysis and inhibitsβ¦
5-Amino-1MQ 50mg | 20-Vial Kit | NNMT Inhibitor
5-Amino-1MQ 50mg | 20-Vial Kit | NNMT Inhibitor
QSC 5-Amino-1MQ (NNMT inhibitor) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Retatrutide 40mg | 10-Vial Kit | 400mg Total | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 40mg | 10-Vial Kit | 400mg Total | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 40mg β triple GLP-1R/GIPR/GCGR agonist, 24.2% Phase 2 weight loss.
Retatrutide + Cagrilintide Blend 10mg | 10-Vial Kit | Triple/Dual Agonist Stack
Retatrutide + Cagrilintide Blend 10mg | 10-Vial Kit | Triple/Dual Agonist Stack
Retatrutide + Cagrilintide Blend 10mg | 10-Vial Kit β Long-acting amylin receptor agonist β reduces food intake via area postrema satiety signalling, slowsβ¦
Mazdutide 5mg | 10-Vial Kit | 50mg Total | GLP-1/GCGR Dual Agonist
Mazdutide 5mg | 10-Vial Kit | 50mg Total | GLP-1/GCGR Dual Agonist
Mazdutide 5mg β dual GLP-1R/GCGR agonist, Phase 3 weight loss compound.
5-Amino-1MQ 5mg | 10-Vial Kit | 50mg Total | NNMT Inhibitor
5-Amino-1MQ 5mg | 10-Vial Kit | 50mg Total | NNMT Inhibitor
5-Amino-1MQ 5mg β NNMT inhibitor, NAD+ elevation, fat oxidation research.
T4 Levothyroxine 40mcg Tablets | 100-Count | Levothyroxine / T4
T4 Levothyroxine 40mcg Tablets | 100-Count | Levothyroxine / T4
T4 Levothyroxine 40mcg Tablets | 100-Count β Thyroid prohormone (levothyroxine) β converted to active T3 by peripheral deiodinases; studied for thyroidβ¦
T3 Liothyronine 40mcg Tablets | 100-Count | Liothyronine / T3
T3 Liothyronine 40mcg Tablets | 100-Count | Liothyronine / T3
T3 Liothyronine 40mcg Tablets | 100-Count β Active thyroid hormone (liothyronine) β direct TRΞ±/TRΞ² agonist responsible for metabolic rate regulation, lipidβ¦
T3 Liothyronine 25mcg Tablets | 100-Count | Liothyronine / T3
T3 Liothyronine 25mcg Tablets | 100-Count | Liothyronine / T3
T3 Liothyronine 25mcg Tablets | 100-Count β Active thyroid hormone (liothyronine) β direct TRΞ±/TRΞ² agonist responsible for metabolic rate regulation, lipidβ¦
BAM15 50mg Tablets | 100-Count | Mitochondrial Uncoupler
BAM15 50mg Tablets | 100-Count | Mitochondrial Uncoupler
QSC BAM15 (selective mitochondrial uncoupler β protonophore, no hyperthermia) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
SLU-PP-332 20mg Tablets | 100-Count | ERR Agonist
SLU-PP-332 20mg Tablets | 100-Count | ERR Agonist
QSC SLU-PP-332 (ERRΞ±/ERRΞ³ nuclear receptor agonist β exercise mimetic) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
SLU-PP-332 5mg Tablets | 100-Count | ERR Agonist
SLU-PP-332 5mg Tablets | 100-Count | ERR Agonist
QSC SLU-PP-332 (ERRΞ±/ERRΞ³ nuclear receptor agonist β exercise mimetic) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
SLU-PP-332 250mcg Tablets | 100-Count | ERR Agonist
SLU-PP-332 250mcg Tablets | 100-Count | ERR Agonist
QSC SLU-PP-332 (ERRΞ±/ERRΞ³ nuclear receptor agonist β exercise mimetic) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tesofensine 500mcg Tablets | 100-Count
Tesofensine 500mcg Tablets | 100-Count
QSC Tesofensine (triple reuptake inhibitor β DA/5HT/NE) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tesamorelin 5mg | 10-Vial Kit | GHRH Analog | Egrifta
Tesamorelin 5mg | 10-Vial Kit | GHRH Analog | Egrifta
QSC Tesamorelin (GHRH(1-44) analog β FDA-approved Egrifta) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Semaglutide 2mg | 10-Vial Kit | GLP-1 Receptor Agonist
Semaglutide 2mg | 10-Vial Kit | GLP-1 Receptor Agonist
QSC Semaglutide (GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Glutathione 1500mg | 10-Vial Kit
Glutathione 1500mg | 10-Vial Kit
Glutathione 1500mg | 10-Vial Kit β Tripeptide master antioxidant (Ξ³-glutamylcysteinylglycine) β primary intracellular reducing agent for ROS, cofactor forβ¦
Retatrutide 60mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 60mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Retatrutide 20mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 20mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Retatrutide 15mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 15mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
5-Amino-1MQ 50mg | 10-Vial Kit | NNMT Inhibitor
5-Amino-1MQ 50mg | 10-Vial Kit | NNMT Inhibitor
QSC 5-Amino-1MQ (NNMT inhibitor) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
5-Amino-1MQ 10mg | 10-Vial Kit | NNMT Inhibitor
5-Amino-1MQ 10mg | 10-Vial Kit | NNMT Inhibitor
QSC 5-Amino-1MQ (NNMT inhibitor) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Cagrilintide 5mg | 10-Vial Kit | Appetite Regulation
Cagrilintide 5mg | 10-Vial Kit | Appetite Regulation
QSC Cagrilintide (Long-acting amylin receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 100mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 100mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Semaglutide 20mg | 10-Vial Kit | GLP-1 Receptor Agonist
Semaglutide 20mg | 10-Vial Kit | GLP-1 Receptor Agonist
QSC Semaglutide (GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Semaglutide 5mg | 10-Vial Kit | GLP-1 Receptor Agonist
Semaglutide 5mg | 10-Vial Kit | GLP-1 Receptor Agonist
QSC Semaglutide (GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Orforglipron 6mg Tablets | 100-Count | GLP-1 Receptor Agonist
Orforglipron 6mg Tablets | 100-Count | GLP-1 Receptor Agonist
QSC Orforglipron (Oral non-peptide GLP-1R agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Orforglipron 12mg Tablets | 100-Count | GLP-1 Receptor Agonist
Orforglipron 12mg Tablets | 100-Count | GLP-1 Receptor Agonist
QSC Orforglipron (Oral non-peptide GLP-1R agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
AOD-9604 10mg | 20-Vial Kit | HGH Fragment
AOD-9604 10mg | 20-Vial Kit | HGH Fragment
AOD-9604 10mg | 20-Vial Kit β Modified GH C-terminal fragment (residues 177-191, Tyr substitution) β stimulates Ξ²3-adrenergic lipolysis and inhibitsβ¦
Retatrutide 5mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
Retatrutide 5mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
MOTS-c 10mg | 10-Vial Kit | Metabolic Regulator
MOTS-c 10mg | 10-Vial Kit | Metabolic Regulator
QSC MOTS-c (Mitochondria-derived peptide) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 20mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 20mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
5-Amino-1MQ 50mg Tablets | 100-Count | NNMT Inhibitor
5-Amino-1MQ 50mg Tablets | 100-Count | NNMT Inhibitor
QSC 5-Amino-1MQ (NNMT inhibitor) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 5mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 5mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
HGH Fragment 176-191 10mg | 10-Vial Kit | Lipolytic Peptide
HGH Fragment 176-191 10mg | 10-Vial Kit | Lipolytic Peptide
HGH Fragment 176-191 10mg | 10-Vial Kit β GH C-terminal fragment (residues 176-191) β activates Ξ²3-adrenergic receptors to drive fat oxidation withoutβ¦
Cagrilintide + Semaglutide Blend 10mg | 10-Vial Kit | Weight Loss Stack
Cagrilintide + Semaglutide Blend 10mg | 10-Vial Kit | Weight Loss Stack
Cagrilintide + Semaglutide Blend 10mg | 10-Vial Kit β Long-acting amylin receptor agonist β reduces food intake via area postrema satiety signalling, slowsβ¦
HGH Fragment 176-191 5mg | 10-Vial Kit | Lipolytic Peptide
HGH Fragment 176-191 5mg | 10-Vial Kit | Lipolytic Peptide
HGH Fragment 176-191 5mg | 10-Vial Kit β GH C-terminal fragment (residues 176-191) β activates Ξ²3-adrenergic receptors to drive fat oxidation withoutβ¦
Mazdutide 10mg | 10-Vial Kit | GLP-1/Glucagon Dual Agonist
Mazdutide 10mg | 10-Vial Kit | GLP-1/Glucagon Dual Agonist
QSC Mazdutide (IBI362, Dual GLP-1R/GCGR agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Survodutide 10mg | 10-Vial Kit | Dual GLP-1/Glucagon Kit
Survodutide 10mg | 10-Vial Kit | Dual GLP-1/Glucagon Kit
QSC Survodutide (Dual GLP-1R/GCGR agonist (BI 456906)) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 50mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 50mg | 10-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.
Tirzepatide 15mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
Tirzepatide 15mg | 20-Vial Kit | Dual GIP/GLP-1 Agonist
QSC Tirzepatide (Dual GIP+GLP-1 receptor agonist) β β₯99% HPLC purity, MS confirmed, Janoshik COA.